drugset / Trial / NCT02072993

A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males

NCT02072993 ↗

Phase 1 Terminated 116 enrolled AstraZeneca
RandomizedParallel-groupSingle-blindBasic science

Summary

This is a first time in human study to assess the safety and tolerability of AZD1979 following oral administration of single ascending doses in healthy male volunteers. Pharmacokinetics (what the body does to the drug) parameters will also be assessed as secondary objectives.

Timeline

Start
2014-03
Primary completion
2014-07
Completion
2014-07

Outcome

Outcome not reported

Stopped: “Study stopping criteria has been reached”

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1979 Unknown — Oral

Indications

No indication recorded.